EXFY · Expensify, Inc.

The thesis

Expensify's shares have rallied to $2.55 on the 22 October 2026 adjusted close, but total revenue is still falling, so the Q3 report (estimated 5 November 2026) decides whether the pivot to New Expensify is turning the company-wide line. The close is 6.3% below the 52-week high of $2.72 and well above the $2.16 weekly close of 11 September 2026 that marked the September breakdown.

The business evidence has not changed since the 6 August 2026 Q2 release. Net revenue was $33.9 million, down 5% year over year, and paid members were 640,000, down 2%. Net-new New Expensify customers added more than $10 million of annual recurring revenue (ARR) across more than 10,000 customers, up more than 250% year over year. The narrative is maturing: the pivot story is well known, and no company disclosure since the 15 September 2026 Claude for Small Business connector announcement has added a revenue figure. The price has moved while the evidence has not. Q2 results

Bullish and bearish views on Expensify, Inc.

The bull case on Expensify, Inc. (EXFY), in brief: New-customer ARR is growing fast. The bear case: Total revenue is still shrinking.

Bull case

• New-customer ARR is growing fast. On 6 August 2026 the company reported more than $10 million of ARR from net-new New Expensify customers, up more than 250% year over year. A higher figure on the same definition at the Q3 report would extend this.
• Cash generation improved. Q2 free cash flow was $6.4 million, and the company raised its fiscal 2026 free-cash-flow guidance to $12 million–$14 million from $6 million–$9 million (Q2 release, 6 August 2026). A June tender offer retired roughly 6.8% of Class A shares outstanding, according to the company's announcement.
• Revenue beat the estimate. Benzinga reported on 6 August 2026 that Q2 sales of $33.866 million beat the $33.688 million analyst estimate. Citizens upgraded the shares to Market Outperform with a $3 price target on 7 August 2026, per Benzinga; that target sits above the $2.55 close.
• AI distribution is widening. Expensify said on 15 September 2026 that its connector is available in Claude for Small Business on paid Claude plans. The announcement gave no usage or revenue figure, so the Q3 report is the first chance to see any effect.

Bear case

• Total revenue is still shrinking. Q2 net revenue fell 5% year over year and paid members fell 2% (Q2 release, 6 August 2026). New-customer growth has not yet turned the company-wide line.
• The shares are up 40.9% over three months, and the 14-day relative strength index (RSI) has risen to 67.2 from 54.2 on 9 October 2026.
• Integrations carry no disclosed sales. The 1 September 2026 Rillet integration and the 15 September 2026 Claude connector were both announced without customer counts or revenue.
• Earnings risk is close. The Q3 report is estimated for 5 November 2026 by MarketBeat; a search on 23 October 2026 found no company-confirmed date. A miss would start from a price 40.9% higher than three months earlier.

Price setup

The adjusted close on 22 October 2026 was $2.55. The 52-week high is $2.72, 6.3% above that close. RSI(14) is 67.2, up from 39.0 on 25 September 2026 and 54.2 on 9 October 2026. A reading near 70 marks a stretched short-term advance without being extreme.

The reference points are the $2.72 52-week high above and the $2.16 weekly close from 11 September 2026 below.

Crowding evidence is mixed. An earnings report is about two weeks away, and the three-month gain is large. No company filings or news headlines since 10 August 2026 add a new buyer or seller; the rally has no new fundamental disclosure behind it.

Catalysts, next 30 days

No upcoming dated catalysts on file — the dated entries below have passed.

Elapsed catalysts

• ~23 October 2026 (est.): Expected announcement of the Q3 report date. The company announced the Q3 2025 date on 23 October 2025 and the Q2 2026 date on 23 July 2026. (passed 14d ago)
• ~5 November 2026 (est.): Q3 2026 financial results, a MarketBeat estimate. The report tests revenue against Q2's $33.9 million, paid members against 640,000 and New Expensify ARR against the $10 million-plus figure. (passed 1d ago)

What would change the view

The case breaks if the shares close below $2.16, the 11 September 2026 weekly close, which would reverse the October recovery and repeat the September breakdown. A Q3 report with revenue under Q2's $33.9 million and paid members falling by more than 2% year over year would show New Expensify is not offsetting legacy losses.

The case strengthens if Q3 revenue holds at or above $33.9 million, or if the company gives a connector adoption figure or a New Expensify ARR number above $10 million. A close above the $2.72 52-week high on such results would show the market accepting the pivot.

What it trades with

Expensify trades as a small-cap software name with a legacy subscription base and a newer product. Its shares react more to its own quarterly report than to sector moves. Citizens' $3 target on 7 August 2026 is the only analyst target in recent news. The Claude connector ties part of the story to AI-assistant distribution, though no revenue from it has been reported.